IntegraGen SA (EPA:ALINT)
0.0750
0.00 (0.00%)
At close: Nov 20, 2026
IntegraGen Revenue
IntegraGen had revenue of 1.98M EUR in the half year ending June 30, 2026, a decrease of -56.65%. This brings the company's total for the last twelve months to 4.44M, down -33.68% year-over-year. In the year 2025, IntegraGen had annual revenue of 5.02M, down -42.28%. That makes IntegraGen the 40,261st largest company in the world by revenue and 526th in France.
Revenue (ttm)
4.44M
Revenue Growth
-33.68%
P/S Ratio
0.12
Revenue / Employee
151.90K
Employees
27
Market Cap
491.77K
Revenue by Geography
- France 4.24M 84.4%
- Export 783.17K 15.6%
Fiscal year ended Dec 31, 2025 See the full IntegraGen breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.02M | -3.68M | -42.28% |
| Dec 31, 2024 | 8.70M | -3.84M | -30.62% |
| Dec 31, 2023 | 12.54M | -629.33K | -4.78% |
| Dec 31, 2022 | 13.17M | 1.84M | 16.27% |
| Dec 31, 2021 | 11.32M | 2.34M | 26.11% |
| Dec 31, 2020 | 8.98M | 699.70K | 8.45% |
| Dec 31, 2019 | 8.28M | 1.36M | 19.62% |
| Dec 31, 2018 | 6.92M | 674.56K | 10.80% |
| Dec 31, 2017 | 6.25M | 225.04K | 3.74% |
| Dec 31, 2016 | 6.02M | 438.41K | 7.85% |
| Dec 31, 2015 | 5.58M | -451.61K | -7.48% |
| Dec 31, 2014 | 6.04M | 627.92K | 11.61% |
| Dec 31, 2013 | 5.41M | 666.66K | 14.06% |
| Dec 31, 2012 | 4.74M | 91.62K | 1.97% |
| Dec 31, 2011 | 4.65M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Advicenne | 10.74M |
| Poxel | 7.66M |
| MaaT Pharma | 3.18M |
| Aelis Farma | 2.19M |
| Oncodesign Precision Medicine Société anonyme | 1.80M |
| Plant Advanced Technologies | 1.35M |
| Aton | 597.00K |
| NFL Biosciences | 3.15K |